Article
Decreased sirtuin 4 expression is associated with poor prognosis in patients with invasive breast cancer
16 Aug 2016
Abstract excerpt
Aberrant metabolism is a hallmark of human cancer. Glutamine metabolism has been identified as a central metabolic pathway in cancer and thus, targeting glutamine metabolism may exhibit therapeutic potential. Sirtuin 4 (SIRT4) is an important molecule that mediates the blockade of glutamine catabolism by inhibiting glutamate dehydrogenase. In the present study, SIRT4 protein expression levels were analyzed in 409...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
